Shares of the company gained about 15 per cent on a YTD basis.

According to the quarterly results, the net sales increased by 185 per cent to Rs 43.1 crore and net profit increased by 137 per cent to Rs 1.68 crore in Q1FY24 over Q1FY23. According to the annual results, the net sales increased by 93 per cent to Rs 114 crore and net profit increased by 350 per cent to Rs 5 crore in FY23 over FY22.

The company has a market cap of Rs 132 crore and is almost debt-free, with only Rs 1.61 crore in debt. This represents just 1.22 per cent of its current market cap. The stock gave multibagger returns of 300 per cent in 2 years and over 600 per cent in 3 years.

After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario.